Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

被引：0
|
作者：
Ghadeer K. Dawwas
Geoffrey D. Barnes
机构：
[1] University of Pennsylvania,Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine
[2] University of Pennsylvania,Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine
[3] Leonard Davis Institute of Health Economics,Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center
[4] University of Pennsylvania,undefined
[5] University of Michigan Health System,undefined
[6] University of Michigan,undefined
[7] North Campus Research Complex,undefined
来源：
Current Cardiology Reports | 2022年 / 24卷
关键词：
Anticoagulants; DOACs; Warfarin; Atrial fibrillation; Valvular heart disease; Stroke;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：731 / 738
页数：7
相关论文
共 50 条
  • [1] Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
    Dawwas, Ghadeer K.
    Barnes, Geoffrey D.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (06) : 731 - 738
  • [2] Direct-acting oral anticoagulants in patients with atrial fibrillation and valvular heart disease
    Canales, Natalie
    Cao, Tina
    Fakourfar, Neeloufar
    Snee, Mara
    Tsu, Laura
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 17 - 18
  • [3] SAFETY AND EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE
    Lippmann, Matthew
    Apte, Nachiket
    Pierpoline, Michael
    Taduru, Siva Sagar
    Dehkordi, Seyed Hamed Hosseini
    Isom, Nicholas
    Dalia, Tarun
    Hacker, Ethan
    Robinson, Alexander
    Buechler, Tyler
    Jazayeri, Mohammad-Ali
    Masoomi, Reza
    Sheldon, Seth
    Reddy, Madhu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 501 - 501
  • [4] Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
    Di Biase, Luigi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [5] Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Aronow, Wilbert S.
    Panza, Julio A.
    Cooper, Howard A.
    HEART, 2019, 105 (18) : 1432 - 1436
  • [6] CLINICAL EVIDENCE IN THE USE OF DIRECT ACTING ORAL ANTICOAGULANTS FOR ATRIAL FIBRILLATION WITH VALVULAR HEART DISEASE
    Engle, Amanda L.
    Rudd, Kelly M.
    Winans, Amanda R. M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E384 - E384
  • [7] Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves
    Dawwas, Ghadeer K.
    Lewis, James D.
    Cuker, Adam
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (04):
  • [8] Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease
    Hampton, Meredith L.
    Tellor, Katie B.
    Armbruster, Anastasia L.
    Theodos, Gus
    Schwarze, Martin W.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (06) : 611 - 617
  • [9] Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease
    Meredith L. Hampton
    Katie B. Tellor
    Anastasia L. Armbruster
    Gus Theodos
    Martin W. Schwarze
    American Journal of Cardiovascular Drugs, 2020, 20 : 611 - 617
  • [10] Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
    Lee, So-Ryoung
    Lee, Hyun-Jung
    Choi, Eue-Keun
    Han, Kyung-Do
    Jung, Jin-Hyung
    Cha, Myung-Jin
    Oh, Seil
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (25) : 3295 - 3308
12345